DOCSLIB.ORG

AOS Directory (Abridged)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

AOS Directory (abridged) March 2016 IN- AND OUT-OF-HOURS SERVICES Trust In Hours Out of Hours A&E Reception Chelsea and Phone: Phone: Phone: Westminster • Acute Oncology 020 3311 5522 (direct line to 020 3315 5813 NHS Foundation BlackBerry 07791 472630 on-call Oncology SpR) Trust • Bleep: 8908 (via (Chelsea and switchboard 020 8746 8000) Westminster Hospital site) Chelsea and Phone: Phone: Phone: Westminster 020 8560 2121 (switchboard) • Oncology: Oncology 020 8321 6256 NHS Foundation Bleep: 719 Registrar via Charing Trust Cross: 020 3311 7866 (West Middlesex • Haematology: on-call University Haematology SpR via the Hospital site) switchboard: 020 8560 2121 Croydon Health Mon–Fri 8am–4pm Phone: Phone: Services NHS Phone: • On-call Oncologist via 020 8401 3000 ext 3016 Trust 020 8401 3000 ext 5726 The Royal Marsden Bleep: 946 Hospital switchboard: Fax: 020 8401 3513 020 8642 6011 Email: mhn- • For Haematology [email protected] Patients, the on-call Haematologist via Croydon University Hospital switchboard: 020 8401 3000 Epsom and St Phone: Phone: Phone: Helier University Kieron Ackerson (AOS • On-call Consultant • Epsom Hospital: Hospitals NHS Administrative Assistant) Oncologist via The Royal 01372 735735 ext Trust Mobile: 07975 232486 Marsden Hospital 6002 Email: Est- switchboard: 020 8642 • St Helier Hospital: [email protected] 6011 020 8296 2275 • For Haematology Patients, the on-call Haematologist via the switchboard: 020 8296 2000 2 IN- AND OUT-OF-HOURS SERVICES Trust In Hours Out of Hours A&E Reception Guy’s and St St Thomas’ Phone: Phone: Thomas’ NHS Phone: 020 7188 7188 On-call Oncology SpR via 020 7188 7188 Foundation Trust Bleep: 0873 switchboard: 020 7188 7188 ext 82134 Mobile: 07833 239430 ext 54197 Guy’s Acute Oncology Assessment Unit Ext: 52423/54217 Bleep: 0537 Imperial College Phone: Phone: Phone: Healthcare NHS Acute Oncology Service 020 3311 5160 Via switchboard Trust Advanced Nurse Practitioners: 020 8333 3000 (Charing Cross Hospital) 020 3311 1966 AOS Consultant/Registrar: Bleep 8082 via main switchboard St Mary’s outreach AOS service – 07717 651376 King’s College Phone: Phone: Phone: Hospital NHS 020 3299 5467 Oncology Registrar on call 020 3299 9000 ext 32400 Foundation Trust Email: [email protected] (via GSTT switchboard 020 (King’s College Page (via switchboard 020 7188 7188) Hospital (KCH) 3299 9000): KH1910 site) King’s College Phone: No out-of-hours service Phone: Hospital NHS 01689 863000 01689 863486 Foundation Trust (Princess Royal AOS Nurse Hospital (PRUH) site) Bleep: 340 Direct line: 01686 863269 Mobile: 07890 252391 Fax: 01689 863270 Email: [email protected] Kingston Phone: Phone: Phone: Hospital NHS 020 8934 2928 • On-call Consultant 020 8546 7711 Foundation Trust Fax: 020 8934 3116 Oncologist via The Royal ext 6147 Bleep: 086 (via switchboard Marsden Hospital 020 8546 7711) switchboard: 020 8642 6011 • For Haematology 3 IN- AND OUT-OF-HOURS SERVICES Trust In Hours Out of Hours A&E Reception Patients, the on-call Haematologist via the Kingston Hospital switchboard: 020 8546 7711 Lewisham and Phone: Phone: Phone: Greenwich NHS 020 8836 6000 – through • Consultant advice is via 020 8836 4360 Trust switchboard Guy’s Hospital (Queen Elizabeth switchboard: 020 7188 Hospital, AOS nurses 7188 Woolwich (QEH) Bleep: 835 • MSCC is through KCH site) Mobile: 07826 530515 switchboard: 020 3299 Fax: 020 8836 5292 9000 Email: SLH- [email protected] Lewisham and Phone: Phone: Phone: Greenwich NHS Through switchboard – 020 • Consultant advice is via Via switchboard Trust 8333 3000 Guy’s Hospital 020 8333 3000 (University switchboard: 020 7188 Hospital For AOS CNS 7188 Lewisham (UHL) Bleep: 1931 • MSCC is through KCH site) Fax: 020 8333 3720 switchboard: 020 3299 Email: 9000 LH.acuteoncologyservice@nhs .net London North Phone: Oncology: Phone: West Healthcare 020 8967 5000 • Clinical/Medical 020 8967 5613 NHS Trust Oncology Registrar (Ealing Hospital AOS Triage Nurse Charing Cross: 020 3311 site) Bleep: 491 7866 Haematology Haematology: Bleep: SPR 083 • Call switchboard (020 8967 5000) for Haematology SpR on call 4 IN- AND OUT-OF-HOURS SERVICES Trust In Hours Out of Hours A&E Reception London North Phone: Phone: Phone: West Healthcare • Oncology CNS 07500 • Oncology: 020 3826 (For clinical staff only) NHS Trust 991950 2020 for SpR on call 020 8869 2108 (Northwick Park • Haematology: (Mount Vernon Hospital) Bleep SpR on 071 (via • Haematology: call and Central switchboard 020 8864 switchboard (020 8864 Middlesex 3232) 3232) for on-call Hospital sites) Haematology SpR Royal Brompton Phone: Phone: No A&E & Harefield NHS Royal Brompton Hospital: Royal Brompton Hospital: Foundation Trust • Lead Cancer Nurse 07531 • 020 3311 5522 (direct 978548 line to on-call Oncology • Thoracic Oncology CNS SpR at Chelsea and Bleep: 7068 Westminster) Harefield Hospital: Harefield Hospital: • Lead Cancer Nurse 07531 • Oncology: 01923 826111 978548 for SpR on call (Mount • Lung CNS Bleep: 6181 Vernon Hospital) Externally for thoracic surgical Externally for thoracic advice surgical advice • Harefield Hospital: • Harefield Hospital: SpR on call 01895 823737 SpR on call 01895 Bleep: 6103 823737 Bleep: 6103 • Royal Brompton Hospital: • Royal Brompton SpR on call 020 7532 8121 Hospital: Bleep: 1339 SpR on call 020 7532 8121 Bleep: 1339 St George’s Phone: Phone: Phone: University Acute Oncology Specialist • On-call Oncology SpR via 020 8725 Hospitals NHS Nurse switchboard: 020 8672 2666/1279/1280 Foundation Trust Bleep: 8226 (via switchboard 1255) 020 8672 1255) • On-call Haematology SpR via switchboard: 020 8672 1255) The Hillingdon Oncology Patients: Oncology Patients: Phone: Hospitals NHS • Phone: 01895 238282 • Phone: 07825 028855 01895 279314 Foundation Trust • Bleep: 5175 Haematology Patients: Haematology Patients: • Phone: Bevan ward • Phone: Bevan ward 01895 01895 279026 279026 Phone: 01895 238282 (Hillingdon switchboard) for on-call Haematology SpR 5 IN- AND OUT-OF-HOURS SERVICES Trust In Hours Out of Hours A&E Reception The Royal Phone: Phone: No A&E Marsden NHS Acute Oncology Administrator Clinical site practitioner Foundation Trust 020 7352 8171 ext 4702 via main switchboard (020 Fax: 020 7808 2306 7352 8171) Central email: rmh- Bleep: 022 (Chelsea) or 017 [email protected] (Sutton) 24-hour consultant advice is Sutton: Ali Hodge, Advanced via main switchboard Nurse Practitioner (Mon–Fri 8.30am–5pm) ext 4225 Chelsea: Melissa Balcorta, Advanced Nurse Practitioner (Tues–Thurs 8.30am–5pm) If not available – clinical contact via clinical site practitioners on either site (see out-of-hours contact) or contact individual teams 6 © London Cancer Alliance 2016 Published by London Cancer Alliance London Cancer Alliance 5th Floor Alliance House 12 Caxton Street London SW1H 0QS www.londoncanceralliance.nhs.uk 7 .
Recommended publications
  • How to Make a Comment Or Complaint

    How to Make a Comment Or Complaint

    How to make a comment or complaint An easy-read guide for people with learning disabilities and their carers Making a comment We would like you to tell us what you think of our hospitals and the support you receive Please tell us if we can do better If you have had a good experience, we would like you to tell us about it This is how you can give us your comments: ●● Speak to someone from our patient advice and liaison service (PALS) ●● Use one of the hand-held computers on the ward or department you are visiting If you are not happy with the care or treatment you receive The Trust hopes to offer good support to all patients Sometimes things go wrong If you are not happy with the support you have received, you should tell us as soon as possible This booklet will tell you: ●● How to complain ●● The steps you will need to take ●● Who can give you support Step 1: how to make an informal complaint If you are not happy you should speak to the hospital staff caring for you Often things can be put right this way If you want to discuss the problem with someone else in the hospital, you can contact PALS, the patient advice and liaison service PALS can speak to the ward or department and try to put things right Using PALS, the patient advice and liaison service Every hospital has a patient advice and liaison team (PALS). They can help you with: ●● Any questions you have about your visit ●● Helping with to put right any problems during your visit ●● Speaking to the ward or department on your behalf We have patient advice and liaison services (PALS)
  • An Introduction to Physiotherapy at Charing Cross Hospital

    An Introduction to Physiotherapy at Charing Cross Hospital

    Musculoskeletal physiotherapy An introduction to physiotherapy Information for patients, relatives and carers What should I bring to my first appointment? Your physiotherapist will need to examine the affected area so please bring a pair of shorts and/or a vest top with you to wear, if appropriate. Please also bring a list of your current medication. If you are fasting please let us know and we will adapt your exercises accordingly. What will happen at my first appointment? Please arrive on time and check in at the kiosk in the physiotherapy department or at the reception desk. If you arrive late for your appointment we may not be able to see you as the clinic usually runs on time. Your appointment will last 30 to 60 minutes. Imperial College Healthcare NHS Trust is an academic health science centre. We may offer you an appointment with a student who works under the supervision of a senior member of staff. If you do not wish to participate in this training please let us know. It will not affect your treatment or care in any way. What if I cannot keep my appointment? If you cannot attend an appointment please let us know at least 24 hours in advance if possible by calling 020 3311 0333 between 08.00 and 17.00, Monday to Friday. The appointment can then be offered to another patient on the waiting list. If you reschedule more than one appointment you may be discharged back to the care of your GP. If you do not attend your appointment you may be discharged from our service in accordance with Trust policy.
  • Buses from Mount Vernon Hospital

    Buses from Mount Vernon Hospital

    Buses from Mount Vernon Hospital White Hill Mount Vernon/ London Road Bishops Wood Hospitals Batchworth Heath The yellow tinted area includes every Northwood Road bus stop up to one-and-a-half miles Shrubs Road from Mount Vernon Hospital. KEWFERR Main stops are shown in the Northwood Road Y D RIV white area outside. Littlebourne Farm E D A T A B HIRLME O C J RE R M OOR Northwood Road GARDEN PARK R S Y OAD R Shepherds Hill House R Y E E E F S A D S EW O W T L E Northwood Road A C Mount Vernon K Hareeld Academy Cricket R G Hospital IC K RO Ground K NE A M DE D A N HAREFIELD SW Hareeld S O RT High Street H NORTHWOOD RO D A D L A Northwood O THE AV M Northwood High Street R South Hareeld E NUE NE Emmanuel Church Moorhall Road L EEN LA T L GR Green Lane I M H H P E Green Lane Y Church Road Northwood High Street G R R L Dene Road S Hallowell Road ’ T E N Moorhall Road K LE C S The Gravel Pits I U D Pinner Road D D E CL Northwood Health Centre W Maxwell Road U V Hawkesworth Close/ Denham WAY Northwood College Nursery School COPSE WOO Northwood Hills Circus DENHAM Y NORTHWOOD Pinner Road Rickmansworth Pinner Green Denham Northgate Maxwell Road PINNER Leaf Close Northwood School Road Oxford Road HILLS Pinner Northwood Hills Duck’s Hill Road Whittington Way Manor House Drive Uxbridge Joel Street 331 Norwich Road The Ridgeway Duck’s Hill Road Jackets Lane Eastcote Whitmore Road Methodist Church Shaftesbury Avenue UXBRIDGE Duck’s Hill Road Reservoir Road Eastcote EASTCOTE Lascelles Avenue Breakspear Road Eastcote Lane Breakspear Crematorium Harrow
  • Report 29: the Impact of the COVID-19 Epidemic on All-Cause Attendances to Emergency Departments in Two Large London Hospitals: an Observational Study

    Report 29: the Impact of the COVID-19 Epidemic on All-Cause Attendances to Emergency Departments in Two Large London Hospitals: an Observational Study

    1 July 2020 Imperial College COVID-19 response team Report 29: The impact of the COVID-19 epidemic on all-cause attendances to emergency departments in two large London hospitals: an observational study Michaela A C Vollmer, Sreejith Radhakrishnan, Mara D Kont, Seth Flaxman, Sam Bhatt, Ceire Costelloe, Kate Honeyford, Paul Aylin, Graham Cooke, Julian Redhead, Alison Sanders, Peter J White, Neil Ferguson, Katharina Hauck, Shevanthi Nayagam, Pablo N Perez-Guzman WHO Collaborating Centre for Infectious Disease Modelling MRC Centre for Global Infectious Disease Analysis Abdul Latif Jameel Institute for Disease and Emergency Analytics (J-IDEA) Division of Digestive Diseases, Department of Metabolism Digestion and Reproduction Imperial College London Imperial College Healthcare NHS Trust Imperial College London Department of Primary Care and Public Health Global Digital Health Unit Correspondence: [email protected] SUGGESTED CITATION Michaela A C Vollmer, Sreejith Radhakrishnan, Mara D Kont et al. The impact of the COVID-19 epidemic on all- cause attendances to emergency departments in two large London hospitals: an observational study. Imperial College London (30-05-2020), doi: https://doi.org/10.25561/80295. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. DOI: https://doi.org/10.25561/80295 Page 1 of 22 1 July 2020 Imperial College COVID-19 response team Summary The health care system in England has been highly affected by the surge in demand due to patients afflicted by COVID-19. Yet the impact of the pandemic on the care seeking behaviour of patients and thus on Emergency department (ED) services is unknown, especially for non-COVID-19 related emergencies.
  • Mount Vernon Cancer Centre Strategic Review Patient and Public Engagement Report - Foreword

    Mount Vernon Cancer Centre Strategic Review Patient and Public Engagement Report - Foreword

    Mount Vernon Cancer Centre Strategic Review Patient and Public Engagement Report - Foreword NHS England, working together with hospital trusts and local commissioners, has been leading a review of the services provided at the Mount Vernon Cancer Centre. We began the review to find a solution to the quality of the buildings as well as clinical challenges such as the limited hospital support there is for patients who are very unwell or have additional health needs. The review has focused on the model of care provided at the centre. This includes the range of services provided, clinical leadership and operational management, and where and how patients can access them. The review is at an early stage and options for the future services will be developed from February 2020. Above all, we want to build on the commitment and expertise of the staff team at Mount Vernon, which we know are well regarded, and to ensure that patients continue to receive high-quality care. We know that there are pressures around the current buildings and premises, and that services must be developed in line with new treatments and approaches to delivering care for people living with cancer. Central to all of this is hearing from patients and their carers – what creates an excellent patient experience, what aspects of the service are most valued by those who use them, and what they would like to see in cancer care developed. To inform this thinking, a series of events and focus group meetings were held between July and September 2019. A survey was also carried out.
  • Ealing Winter Resilience Health and Adult Social Care Scrutiny Panel 25 November 2015

    Ealing Winter Resilience Health and Adult Social Care Scrutiny Panel 25 November 2015

    EALING WINTER RESILIENCE HEALTH AND ADULT SOCIAL CARE SCRUTINY PANEL 25 NOVEMBER 2015 INTRODUCTION This report details the Ealing Winter Resilience plans and performance to date across the key providers of the local health and social care system. The key organisations contributing to this report are Ealing CCG, London Ambulance Service, London North West Hospitals NHS Trust, Imperial College Healthcare NHS Trust, and Ealing Adult Social Care. The plans are facilitated and co-ordinated through the Ealing System Resilience Group (SRG), also known as the Ealing Urgent Care Board which meets on a monthly basis. The report covers the capacity required to ensure the safe delivery of effective, high quality accessible integrated services. The paper also highlights the public and patient winter campaign to ensure the use of right service at the right time. The following summarises SRG resilience plan, demonstrating how Ealing CCG and Council are working with partners to deliver consistent 4 hour performance in 15/16. This document builds on identified SRG actions and takes account of the 8 High Impact Interventions (‘what good looks like’) from NHSE. 1 KEY SCHEMES The following summarises the key additional resources invested from system resilience funding and Better Care Fund to enable safe and efficient management during winter. These schemes are based on the winter debrief form 2014/15 and lessons learnt. Organisation Scheme £ 1 LNWHT Discharge Co-ordinators – 7day working - To facilitate £219,016 discharges on all the wards particularly for
  • Route H11 : Route Record Harrow Bus Station – Mount Vernon Hospital

    Route H11 : Route Record Harrow Bus Station – Mount Vernon Hospital

    Route H11 : Route Record Harrow Bus Station – Mount Vernon Hospital Start Date : 12 April 2008 Reason for Issue : Addition of turning point Streets Traversed Towards Mount Vernon Hospital: College Road, Bessborough Road, Lascelles Avenue, Treve Avenue, Whitmore Road, Shaftesbury Avenue, The Ridgeway, Suffolk Road, Rayners Lane, Whittington Way, Cannon Lane, Eastcote Road, Marsh Road, Bridge Street, Elm Park Road, Pinner Green, Rickmansworth Road, Pinner Road, Northwood Hills Circus, Pinner Road, Northwood High Street, Church Road, Northwood Way, Green Lane, Rickmansworth Road, Private Road In Mount Vernon Hospital Grounds. Towards Harrow Bus Station: Private Road In Mount Vernon Hospital Grounds, Rickmansworth Road, Green Lane, Northwood Way, Church Road, Northwood High Street, Pinner Road, Northwood Hills Circus, Pinner Road, Rickmansworth Road, Pinner Green, Elm Park Road, Bridge Street, Marsh Road, Eastcote Road, Cannon Lane, Whittington Way, Rayners Lane, Suffolk Road, The Ridgeway, Shaftesbury Avenue, Whitmore Road, Treve Avenue, Lascelles Avenue, Bessborough Road, Circumnavigate Roundabout At Junction Of Greenhill Way, Bessborough Road, Pinner Road, Bessborough Road, College Road, Headstone Road, Kymberley Road, Harrow Bus Station. Page 1 of 4 Stands And Turning Points HARROW BUS STATION Private stand for 7 buses in marked bays in Harrow Bus Station on south side of College Road. Buses proceed from Harrow Bus Station direct to stand, departing via Harrow Bus Station to College Road. Set down in Harrow Bus Station, at Stop E and pick up in College Road, at Stop D. AVAILABILITY: At any time. OPERATING RESTRICTIONS: No more than 1 bus on Route H11 should be scheduled to stand at any one time. MEAL RELIEFS: No meal relief vehicles to stand at any time.
  • Trial of Isotretinoin and Calcitriol Monitored by CA 125 in Patients with Ovarian Cancer

    Trial of Isotretinoin and Calcitriol Monitored by CA 125 in Patients with Ovarian Cancer

    Britsh Joumal of Cancer (1996) 74, 1479-1481 © 1996 Stockton Press All rights reserved 0007-0920/96 $12.00 Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer GJS Rustin', TG Quinnell', J Johnson', H Clarke2, AE Nelstrop' and W Bollag3 'Department of Medical Oncology, Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK; 2Department of Medical Oncology, Charing Cross Hospital, London W6 8RF, UK; 3Pharmaceutical Research, F Hoffmann-La Roche Ltd., CH-4002, Basle, Switzerland. Summary Twenty-two asymptomatic women with rising CA 125 levels after chemotherapy for ovarian cancer were entered into a trial of isotretinoin combined with calcitriol. Tumours were evaluated according to precise criteria based on serial CA 125 levels and by comparing regression slopes of CA 125 before and during therapy. There was no evidence based on CA 125 of any responses or significant change in tumour growth rate. Keywords: calcitriol; isotretinoin; CA 125; ovarian cancer Retinoids have been shown in vitro and in animal disease, defined as a CA 125 level that had risen to more than experiments to have inhibitory activity against a wide range 100 U ml-'; a Karnofsky performance status of at least 60; of solid tumours. The single-agent activity in man has been an ability to take oral medication; a serum creatinine less disappointing apart from in acute promyelocytic leukaemia than 1.5 x upper limit of normal; LFTs and bilirubin less (Smith et al., 1992). However, combination therapy with than 2 x upper limit of normal; serum calcium within normal interferon has shown considerable activity against cervical range; and no serious concomitant physical or psychiatric carcinoma (Lippman et al., 1992).
  • Radiation Protection Research and Training Programme 1990-91

    Radiation Protection Research and Training Programme 1990-91

    * * Commission of the European Communities radiation protection Radiation protection research and training programme 1990-91 Catalogue of contracts Commission of the European Communities radiation protection Radiation protection research and training programme 1990-91 Catalogue of contracts Edited by: Commission of the European Communities Environment, Consumer Protection and Nuclear Safety Rue de la Loi 200 B-1049 Brussels Directorate-General r ii ./■...!. Science, Research and Development I PAN., i,::? " r c 1991 „ 0 '- - EUR 13387 EN Published by the COMMISSION OF THE EUROPEAN COMMUNITIES Directorate-General Telecommunications, Information Industries and Innovation L-2920 Luxembourg LEGAL NOTICE Neither the Commission of the European Communities nor any person acting on behalf of the Commission is responsible for the use which might be made of the following information Cataloguing data can be found at the end of this publication Luxembourg: Office for Official Publications of the European Communities, 1991 ISBN 92-826-2525-7 Catalogue number: CD-NA-13387-EN-C © ECSC-EEC-EAEC, Brussels • Luxembourg, 1991 Printed in Belgium Preface: The Community Radiation Protection Research and Training Programme was initiated in the framework of the EURATOM TREATY almost 30 years ago. During this time it has undergone major changes in adapting itself to new research needs in relation to the changing demands of radiation protection policies and practices and to new applications of ionizing radiation. The present catalogue of contracts which presents a complete overview of the 1990-1991 Radiation Protection Programme bears witness to this. The Commission now favours multi-partner contracts which allow an even better integration of the work of different institutes into a common goal.
  • Use of Non-Invasive Optical Analysis in Neurosurgery – a Pilot Study

    Use of Non-Invasive Optical Analysis in Neurosurgery – a Pilot Study

    Joint Research Compliance Office Use of non-invasive optical analysis in Neurosurgery – A pilot study Study Protocol 30/12/2019, Version 2.0 MAIN SPONSOR: Imperial College London FUNDERS: BrAin Tumour ReseArch STUDY COORDINATION CENTRE: Charing Cross Hospital – ImperiAl College NHS Trust IRAS Project ID: 258210 REC reference: Chief Investigator: Mr Kevin O’Neill, Dan Elson Co-investigators: Mr Giulio Anichini – Study coordinator, also responsible for patients’ recruitment, intra- operative data acquisition, data analysis, writing and submission of the research. Mr Neekhil Patel – Responsible for patients’ recruitment, intra-operative data acquisition, and data analysis Mr David Peterson - Responsible for patients’ recruitment and intra-operative data acquisition IRAS Project ID: 258210 Version 2.0, 30/12/2019 1 Joint Research Compliance Office Professor Dan Elson, Dr Iani Gayo, Dr Ioannis Gkouzionis, Dr Maria Leiloglou, Dr Vadzim Chalau, Dr Elizabeth Noble – Responsible for data processing and analysis Mr Babar Vaqas – Responsible for data analysis, writing and submission review Statistician: members of ICL / Hamlyn Center – to be defined Study Coordination Centre For general queries, supply of study documentation, and collection of data, please contact: Study Coordinator: Mr Giulio Anichini Address: Charing Cross Hospital, 3rd Floor South Corridor, Fulham Palace Rd, Hammersmith, London W6 8RF Registration: GMC 7422941 Tel: 020 3311 7678 E-mail: [email protected], [email protected] CLINICAL QUERIES Clinical queries should be directed to Mr Giulio Anichini, who will direct the query to the appropriate person IRAS Project ID: 258210 Version 2.0, 30/12/2019 2 Joint Research Compliance Office SPONSOR Imperial College of London is the main research Sponsor for this study.
  • Position Specification

    Position Specification

    Private and Confidential Position Specification North West London Pathology Chief Executive Reference 1707-022L Final Doc#868505 INTRODUCTION Background North West London Pathology (NWLP) has recently been set up as a Joint Venture owned by three Trusts across North West London: Imperial College Healthcare NHS Trust, Chelsea and Westminster Hospital NHS Foundation Trust, and Hillingdon Hospitals NHS Foundation Trust. NWLP is hosted by Imperial College Healthcare NHS Trust, which itself comprises fives hospitals, namely, Charing Cross, Hammersmith, Queen Charlotte’s & Chelsea, St Mary’s, and Western Eye Hospital. The pathology service offered by NWLP is one of the largest and most comprehensive in the UK, offering a wide range of diagnostic and clinical support services to GPs across London, as well as to other NHS institutions. Pathology laboratories are situated across all the hospitals in NWLP, although concentrated at the Charing Cross Hospital, which hosts a large and sophisticated automated laboratory, a centralised microbiology laboratory, specialised biochemistry services, a tumour marker laboratory, and a drugs-of-abuse department. Molecular diagnostics services provided at the Hammersmith Hospital. Clinical excellence and continued quality improvement is embedded in Imperial College Healthcare NHS Trust’s values and, for over ten years, the Trust and its Partners have maintained full and continuous accreditation, as awarded by Clinical Pathology Accreditation (UK) Ltd. With an overall value estimated between £2 to £3 billion -- and increasing -- the pathology market- place in the UK presents attractive opportunities. Increases in the number of consultations at GP practices has put additional demands on the resources available for patient management. NWLP’s pathology services are designed and being delivered to meet this rise in numbers.
  • Report of the Six Authority Joint Health Overview & Scrutiny Committee

    Report of the Six Authority Joint Health Overview & Scrutiny Committee

    London Borough of Harrow Report of the six authority Joint Health Overview & Scrutiny Committee Response to the consultation paper “Investing in Your Health” issued by the Bedfordshire and Hertfordshire Strategic Health Authority as it relates to the future of the non-surgical oncology facility at Mount Vernon Hospital and the related consultation paper from the North West London Strategic Health Authority entitled “Mount Vernon Hospital: The Future of Services for Cancer Patients” MEMBERS OF THE COMMITTEE Cllr David Reedman (Bedfordshire County Council), Cllr Duncan Ross (Bedfordshire County Council), Cllr Pauline Wilkinson (Buckinghamshire County Council), Cllr Jennifer Woolveridge (South Bucks District Council, representing Buckinghamshire Health Scrutiny Committee), Cllr Eric Silver (London Borough of Harrow), Cllr Marie-Louise Nolan (London Borough of Harrow), Cllr Ken Coleman (Hertfordshire County Council), Cllr Roma Mills (Hertfordshire County Council) Cllr Mary O’Connor (London Borough of Hillingdon), Cllr David Horne (London Borough of Hillingdon) – Chairperson Cllr Anna Pederson (Luton Borough Council), Cllr Sian Timoney (Luton Borough Council) September 2003 CONTENTS Introduction ...........................................................................................................................1 Statutory Basis for this Submission ...................................................................................1 Composition of the Joint Committee ..................................................................................1